Literature DB >> 16652275

Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.

Laura L Hammitt1, Dana L Bruden, Jay C Butler, Henry C Baggett, Debby A Hurlburt, Alisa Reasonover, Thomas W Hennessy.   

Abstract

BACKGROUND: Use of heptavalent protein-polysaccharide pneumococcal conjugate vaccine (PCV7) has been associated with decreases in PCV7-type invasive pneumococcal disease and nasopharyngeal (NP) carriage in children. Vaccine use has also indirectly decreased the rate of invasive disease in adults, presumably through decreased transmission of pneumococci from vaccinated children to adults.
METHODS: We conducted NP carriage surveys in 8 villages in Alaska in 1998-2004. Streptococcus pneumoniae isolates were characterized by serotype and antimicrobial susceptibility. We analyzed trends in serotype distribution, antibiotic resistance, and factors associated with adult carriage of PCV7-serotype pneumococci before and after the introduction of PCV7 in 2001.
RESULTS: We collected 15,598 NP swabs; overall, 52% of adults living in the villages surveyed participated in the colonization study. The proportion of adult carriers with PCV7-type pneumococcal carriage decreased from 28% of carriers in 1998-2000 to 4.5% of carriers in 2004 (P<.0001). Among adults, the proportion of colonizing isolates that were resistant to penicillin decreased from 13% in 1998-2000 to 6% in 2004 (P=.05), whereas the percentage of isolates with intermediate susceptibility to penicillin increased from 12% in 1998-2000 to 19% in 2004 (P<.01). Adults were more likely to carry PCV7-type pneumococci if they lived with a child <5 years old or if they lived with a child who had not been age-appropriately vaccinated with PCV7.
CONCLUSIONS: Pediatric vaccination with PCV7 has resulted in decreased PCV7-type pneumococcal carriage among adults and helps to explain recent decreases in the rate of PCV7-type invasive pneumococcal disease among adults.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16652275     DOI: 10.1086/503805

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  92 in total

1.  Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster.

Authors:  F M Russell; J R Carapetis; C Satzke; L Tikoduadua; L Waqatakirewa; R Chandra; A Seduadua; S Oftadeh; Y B Cheung; G L Gilbert; E K Mulholland
Journal:  Clin Vaccine Immunol       Date:  2010-10-13

2.  MicroRNA-155 is required for clearance of Streptococcus pneumoniae from the nasopharynx.

Authors:  Chris P Verschoor; Michael G Dorrington; Kyle E Novakowski; Julie Kaiser; Katherine Radford; Parameswaran Nair; Varun Anipindi; Charu Kaushic; Michael G Surette; Dawn M E Bowdish
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

Review 3.  Serotype replacement in disease after pneumococcal vaccination.

Authors:  Daniel M Weinberger; Richard Malley; Marc Lipsitch
Journal:  Lancet       Date:  2011-04-12       Impact factor: 79.321

4.  Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine.

Authors:  N Grall; O Hurmic; M Al Nakib; M Longo; C Poyart; M-C Ploy; E Varon; J Raymond
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-18       Impact factor: 3.267

5.  Detection and characterization of Mycoplasma pneumoniae during an outbreak of respiratory illness at a university.

Authors:  Jessica L Waller; Maureen H Diaz; Brianna L Petrone; Alvaro J Benitez; Bernard J Wolff; Laura Edison; Melissa Tobin-D'Angelo; Ashley Moore; Audrey Martyn; Hope Dishman; Cherie L Drenzek; Kim Turner; Lauri A Hicks; Jonas M Winchell
Journal:  J Clin Microbiol       Date:  2013-12-26       Impact factor: 5.948

6.  Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens.

Authors:  Maja Kodani; Genyan Yang; Laura M Conklin; Tatiana C Travis; Cynthia G Whitney; Larry J Anderson; Stephanie J Schrag; Thomas H Taylor; Bernard W Beall; Robert F Breiman; Daniel R Feikin; M Kariuki Njenga; Leonard W Mayer; M Steven Oberste; Maria Lucia C Tondella; Jonas M Winchell; Stephen L Lindstrom; Dean D Erdman; Barry S Fields
Journal:  J Clin Microbiol       Date:  2011-04-06       Impact factor: 5.948

7.  Serotyping of Streptococcus pneumoniae isolates from nasopharyngeal samples: use of an algorithm combining microbiologic, serologic, and sequential multiplex PCR techniques.

Authors:  Karen Miernyk; Carolynn Debyle; Marcella Harker-Jones; Kimberlee Boyd Hummel; Thomas Hennessy; Jay Wenger; Karen Rudolph
Journal:  J Clin Microbiol       Date:  2011-07-20       Impact factor: 5.948

8.  Impact of 13-Valent Pneumococcal Conjugate Vaccination on Streptococcus pneumoniae Carriage in Young Children in Massachusetts.

Authors:  Grace M Lee; Ken Kleinman; Stephen I Pelton; William Hanage; Susan S Huang; Matthew Lakoma; Maya Dutta-Linn; Nicholas J Croucher; Abbie Stevenson; Jonathan A Finkelstein
Journal:  J Pediatric Infect Dis Soc       Date:  2013-10-03       Impact factor: 3.164

9.  Penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effect on susceptibility categorisation in Germany (1997-2013).

Authors:  M Imöhl; R R Reinert; P M Tulkens; M van der Linden
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-15       Impact factor: 3.267

Review 10.  Preventing pneumococcal disease in the elderly: recent advances in vaccines and implications for clinical practice.

Authors:  Angel Vila-Corcoles; Olga Ochoa-Gondar
Journal:  Drugs Aging       Date:  2013-05       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.